Get informed when a big investor buys or sells
+ FollowOvervalued by 120.6% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $11.46 Million |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $-0.01 |
| Beta | -0.27 |
| Outstanding Shares | 260,040,591 |
| P/E Ratio | -8 |
|---|---|
| PEG | 81.22 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
No data
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 0.06%▼ 0.00% |
|---|---|
| Total Invested | $9,000▲ 12.50% |
| Investors Holding | 10% |
Based in Henderson, Nevada, United Health Products, Inc., established in 1997, focuses on the creation, production, and distribution of hemostatic gauze solutions throughout the United States. This company primarily caters to the healthc...